Cutia Therapeutics (HKSE:02487) Price-to-Tangible-Book : 1.24 (As of May. 31, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cutia Therapeutics Price-to-Tangible-Book?

As of today (2024-05-31), Cutia Therapeutics's share price is HK$7.20. Cutia Therapeutics's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was HK$5.79. Hence, Cutia Therapeutics's Price to Tangible Book Ratio of today is 1.24.

The historical rank and industry rank for Cutia Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

HKSE:02487' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.45 Med: 4.23 Max: 4.23
Current: 1.5

During the past 3 years, Cutia Therapeutics's highest Price to Tangible Book Ratio was 4.23. The lowest was 1.45. And the median was 4.23.

HKSE:02487's Price-to-Tangible-Book is ranked better than
74.82% of 1219 companies
in the Biotechnology industry
Industry Median: 2.77 vs HKSE:02487: 1.50

A closely related ratio is called PB Ratio. As of today, Cutia Therapeutics's share price is HK$7.20. Cutia Therapeutics's Book Value per Sharefor the quarter that ended in Jun. 2023 was HK$5.82. Hence, Cutia Therapeutics's P/B Ratio of today is 1.24.

Cutia Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Cutia Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cutia Therapeutics Price-to-Tangible-Book Chart

Cutia Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

1.53

Cutia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	-	-	-	4.23	2.29

Competitive Comparison of Cutia Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Cutia Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cutia Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cutia Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cutia Therapeutics's Price-to-Tangible-Book falls into.

Cutia Therapeutics Price-to-Tangible-Book Calculation

Cutia Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	7.20	/	5.786
	=	1.24

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Cutia Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cutia Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Cutia Therapeutics (HKSE:02487) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cutia Therapeutics (HKSE:02487) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

436 Heng Feng Road, 20th Floor, Huanzhi Building, Jingan District, Shanghai, CHN, 200070

Website

https://www.cutiatx.com

Cutia Therapeutics is a dermatology-focused biopharmaceutical company focused on the broader dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. Its core product is CU-20401, which is a recombinant mutant collagenase that targets obesity, overweight, or other localized adipose accumulation-associated metabolic diseases.

Executives

Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Shen Nan Peng	2201 Interest of corporation controlled by you
Snp China Enterprises Limited	2201 Interest of corporation controlled by you
Hongshan Capital Growth Fund V, L.p.	2201 Interest of corporation controlled by you
Hsg Growth V Holdco Q, Ltd	2201 Interest of corporation controlled by you
Hsg Growth V Management, L.p.	2201 Interest of corporation controlled by you
Hsg Holding Limited	2201 Interest of corporation controlled by you
Ma Yun	2201 Interest of corporation controlled by you
Su Zhou Tong Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Su Zhou Yun Zhang Tou Zi Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Tong He Er Qi Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Su Zhou Fu Yan Chuang Ye Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Aurora Cutis Limited	2301 Trustee

Cutia Therapeutics (HKSE:02487) Headlines

No Headlines